OBJECTIVES: To estimate the prevalence and associated risk factors of hepatitis B virus (HBV) serological markers in female sex workers (FSW) in Mexico City. METHODS: The study population consisted of 1498 FSW who attended a detection centre for human immunodeficiency virus (HIV) in Mexico City, between January and October 1992. Study participants responded to a standardised questionnaire and provided a blood sample for serology of syphilis, HIV, and HBV. RESULTS: A total of 0.2% (95% CI 0.1-0.3) of the population were hepatitis B surface antigen (HBsAg) carriers. The general prevalence of antibodies to hepatitis B core antigen (anti-HBc) was 6.3% (95% CI 5.5-7.1). This marker of previous exposition to HBV, was independently associated by logistic regression multivariate analysis with age, working in the street, and history of blood transfusion (BT) before 1987 (OR 4.8, 95% CI 2.1-11.3). Syphilis prevalence was 7.6% (95% CI 6.2-8.9) and HIV prevalence was 0.1% (95% CI 0-0.3). CONCLUSIONS: The prevalence of HBV infection in this group of Mexican FSW is lower than previously reported in other countries. In addition, the frequency of HBsAg carriers is similar to that in the general Mexican population. The absence of two major risk factors for HBV transmission in this group of FSW--that is, injecting drug use and anal intercourse, could help to explain this finding. However, the positive association between anti-HBc and history of blood transfusion demonstrated here, highlights the need to reinforce strict control of blood supplies in Mexico.
OBJECTIVES: To estimate the prevalence and associated risk factors of hepatitis B virus (HBV) serological markers in female sex workers (FSW) in Mexico City. METHODS: The study population consisted of 1498 FSW who attended a detection centre for human immunodeficiency virus (HIV) in Mexico City, between January and October 1992. Study participants responded to a standardised questionnaire and provided a blood sample for serology of syphilis, HIV, and HBV. RESULTS: A total of 0.2% (95% CI 0.1-0.3) of the population were hepatitis B surface antigen (HBsAg) carriers. The general prevalence of antibodies to hepatitis B core antigen (anti-HBc) was 6.3% (95% CI 5.5-7.1). This marker of previous exposition to HBV, was independently associated by logistic regression multivariate analysis with age, working in the street, and history of blood transfusion (BT) before 1987 (OR 4.8, 95% CI 2.1-11.3). Syphilis prevalence was 7.6% (95% CI 6.2-8.9) and HIV prevalence was 0.1% (95% CI 0-0.3). CONCLUSIONS: The prevalence of HBV infection in this group of Mexican FSW is lower than previously reported in other countries. In addition, the frequency of HBsAg carriers is similar to that in the general Mexican population. The absence of two major risk factors for HBV transmission in this group of FSW--that is, injecting drug use and anal intercourse, could help to explain this finding. However, the positive association between anti-HBc and history of blood transfusion demonstrated here, highlights the need to reinforce strict control of blood supplies in Mexico.
Authors: F Uribe-Salas; M Hernández-Avila; C J Conde-González; L Juárez-Figueroa; B Allen; R Anaya-Ocampo; C Del Río-Chiriboga; P Uribe-Zúñiga; B de Zalduondo Journal: Am J Public Health Date: 1997-06 Impact factor: 9.308
Authors: L Rosenblum; W Darrow; J Witte; J Cohen; J French; P S Gill; J Potterat; K Sikes; R Reich; S Hadler Journal: JAMA Date: 1992-05-13 Impact factor: 56.272
Authors: L A Juárez-Figueroa; F J Uribe-Salas; C J Conde-Glez; M Hernández-Avila; P Hernández-Nevárez; P Uribe-Zúñiga; C del Río-Chiriboga Journal: Sex Transm Dis Date: 1997-04 Impact factor: 2.830
Authors: K C Hyams; J Escamilla; R Lozada Romero; E Macareno Alvarado; N Bonilla Giraldo; T J Papadimos; C Rubio Martinez; P Garcia Gonzalez Journal: Scand J Infect Dis Date: 1990
Authors: A Orduña; M A Bratos; P Gutierrez; A Almaraz; J M Eiros; J F Martín; J M Gonzalez; A Caro-Patón; A Rodríguez-Torres Journal: Eur J Epidemiol Date: 1992-09 Impact factor: 8.082
Authors: M A Bratòs; J M Eiros; A Orduña; M Cuervo; R Ortiz de Lejarazu; A Almaraz; J F Martín-Rodríguez; M P Gutiérrez-Rodríguez; E Orduña Prieto; A Rodríguez-Torres Journal: Sex Transm Dis Date: 1993 Sep-Oct Impact factor: 2.830
Authors: L A Lettau; J G McCarthy; M H Smith; S C Hadler; L J Morse; T Ukena; R Bessette; A Gurwitz; W G Irvine; H A Fields Journal: N Engl J Med Date: 1987-11-12 Impact factor: 91.245
Authors: K C Hyams; I A Phillips; A Tejada; O Li; P Hermoza; F Lopez; P Alva; G Chauca; S Sanchez; F S Wignall Journal: J Infect Dis Date: 1990-08 Impact factor: 5.226
Authors: Branwen Nia Owen; Rebecca F Baggaley; Jocelyn Elmes; Amy Harvey; Zara Shubber; Ailsa R Butler; Romain Silhol; Peter Anton; Barbara Shacklett; Ariane van der Straten; Marie-Claude Boily Journal: AIDS Behav Date: 2020-03